(0.62%) 5 114.00 points
(0.11%) 38 329 points
(0.86%) 17 718 points
(0.18%) $83.72
(-3.36%) $1.583
(0.87%) $2 362.80
(1.27%) $27.70
(0.58%) $925.80
(-0.02%) $0.932
(0.25%) $10.98
(-0.03%) $0.799
(-0.11%) $92.07
Live Chart Being Loaded With Signals
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves...
Stats | |
---|---|
Today's Volume | 38 400.00 |
Average Volume | 48 998.00 |
Market Cap | 33.34B |
EPS | ¥0 ( 2024-02-06 ) |
Next earnings date | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥14.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 19.62 |
ATR14 | ¥1.174 (0.10%) |
Volume Correlation
WIN-Partners Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
WIN-Partners Co., Ltd. Correlation - Currency/Commodity
WIN-Partners Co., Ltd. Financials
Annual | 2022 |
Revenue: | ¥70.85B |
Gross Profit: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Revenue: | ¥70.85B |
Gross Profit: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Revenue: | ¥66.39B |
Gross Profit: | ¥8.52B (12.83 %) |
EPS: | ¥63.88 |
FY | 2021 |
Revenue: | ¥62.12B |
Gross Profit: | ¥7.74B (12.47 %) |
EPS: | ¥53.66 |
Financial Reports:
No articles found.
WIN-Partners Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥14.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥12.50 | 2011-03-29 |
Last Dividend | ¥14.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥255.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.11 | -- |
Div. Sustainability Score | 5.79 | |
Div.Growth Potential Score | 4.00 | |
Div. Directional Score | 4.89 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8289.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
7679.T | Ex Dividend Knight | 2024-02-28 | Annually | 0 | 0.00% | |
6856.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6210.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4931.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4109.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3321.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
2395.T | Ex Dividend Junior | 2023-09-28 | Sporadic | 0 | 0.00% | |
9319.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8046.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0228 | 1.500 | 9.54 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0381 | 1.200 | 8.73 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0758 | 1.500 | -0.268 | -0.403 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.697 | 0.800 | 4.72 | 3.78 | [0.8 - 2.5] |
cashRatioTTM | 0.825 | 1.500 | 6.53 | 9.79 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 196 918 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 3.17 | 6.35 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.123 | 1.000 | -1.278 | -1.278 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.365 | -1.365 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.674 | 0.800 | 2.17 | 1.737 | [0.5 - 2] |
Total Score | 5.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 19.59 | 1.000 | 8.12 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0758 | 2.50 | -0.173 | -0.403 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 6.35 | [0 - 30] |
dividendYielPercentageTTM | 4.30 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.534 | 1.500 | 3.11 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00524 | 1.000 | -2.37 | 0 | [0.1 - 0.5] |
Total Score | 4.00 |
WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators